Dunn, S L <br/><br/>
Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.  [electronic resource] 

 -  Osteoarthritis and cartilage  Jan 2014 
 - 133-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9653 
<br/><br/><label>Standard No.: </label>10.1016/j.joca.2013.10.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alginates<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Benzoxazines--pharmacology<br/>Cartilage, Articular--metabolism<br/>Cell Death--drug effects<br/>Cells, Cultured<br/>Chondrocytes--drug effects<br/>Drug Evaluation, Preclinical--methods<br/>Gene Expression Regulation--drug effects<br/>Glucuronic Acid<br/>Hexuronic Acids<br/>Humans<br/>Interleukin-1beta--antagonists & inhibitors<br/>Matrix Metalloproteinase 13--biosynthesis<br/>Matrix Metalloproteinase 3--biosynthesis<br/>Matrix Metalloproteinases--biosynthesis<br/>Morpholines--pharmacology<br/>Naphthalenes--pharmacology<br/>Osteoarthritis, Knee--metabolism<br/>Receptors, Cannabinoid--metabolism<br/>Tissue Inhibitor of Metalloproteinase-1--biosynthesis<br/>Tissue Inhibitor of Metalloproteinase-2--biosynthesis<br/>Tissue Inhibitor of Metalloproteinases--biosynthesis